UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Drug discovery effectiveness from the standpoint of therapeutic mechanisms and indications

Nature reviews. Drug discovery, 2018-01, Vol.17 (1), p.19-33

2018

Volltextzugriff (PDF)

Common Pharmacophores for Uncharged Human Ether-a-go-go-Related Gene (hERG) Blockers

Journal of medicinal chemistry, 2006-11, Vol.49 (23), p.6917-6921

Aronov, Alex M

2006

Volltextzugriff (PDF)

Predictive in silico modeling for hERG channel blockers

Drug Discovery Today, 2005-01, Vol.10 (2), p.149-155

Aronov, Alex M.

2005

Volltextzugriff (PDF)

Targeting the MAPK Signaling Pathway in Cancer: Promising Preclinical Activity with the Novel Selective ERK1/2 Inhibitor BVD-523 (Ulixertinib)

Molecular cancer therapeutics, 2017-11, Vol.16 (11), p.2351-2363

2017

Volltextzugriff (PDF)

Drug discovery effectiveness from the standpoint of therapeutic mechanisms and indications

Nature reviews. Drug discovery, 2018-01, Vol.17 (1), p.78-78

2018

Volltextzugriff (PDF)

Ligand structural aspects of hERG channel blockade

Current topics in medicinal chemistry, 2008-09, Vol.8 (13), p.1113-1127

Aronov, Alex M

2008

Volltextzugriff (PDF)

Prediction of Protein Pairs Sharing Common Active Ligands Using Protein Sequence, Structure, and Ligand Similarity

Journal of chemical information and modeling, 2016-09, Vol.56 (9), p.1734-1745

2016

Volltextzugriff (PDF)

Structural Basis for Isoform Selectivity in a Class of Benzothiazole Inhibitors of Phosphoinositide 3‑Kinase γ

Journal of medicinal chemistry, 2015-01, Vol.58 (1), p.517-521

2015

Volltextzugriff (PDF)

Kinase-likeness and Kinase-Privileged Fragments: Toward Virtual Polypharmacology

Journal of medicinal chemistry, 2008-03, Vol.51 (5), p.1214-1222

2008

Volltextzugriff (PDF)

Smallest Maximum Intramolecular Distance: A Novel Method to Mitigate Pregnane Xenobiotic Receptor Activation

Journal of chemical information and modeling, 2020-04, Vol.60 (4), p.2091-2099

2020

Volltextzugriff (PDF)

Fragment-Based Discovery of Dual JC Virus and BK Virus Helicase Inhibitors

Journal of medicinal chemistry, 2016-08, Vol.59 (15), p.7138-7151

2016

Volltextzugriff (PDF)

Structure-Guided Design of Potent and Selective Pyrimidylpyrrole Inhibitors of Extracellular Signal-Regulated Kinase (ERK) Using Conformational Control

Journal of medicinal chemistry, 2009-10, Vol.52 (20), p.6362-6368

2009

Volltextzugriff (PDF)

Discovery of Potent, Selective Triazolothiadiazole-Containing c‑Met Inhibitors

ACS medicinal chemistry letters, 2021-06, Vol.12 (6), p.955-960

2021

Volltextzugriff (PDF)

Discovery of Highly Isoform Selective Thiazolopiperidine Inhibitors of Phosphoinositide 3‑Kinase γ

Journal of medicinal chemistry, 2015-07, Vol.58 (14), p.5684-5688

2015

Volltextzugriff (PDF)

Discovery of a Novel Series of Potent and Selective Alkynylthiazole-Derived PI3Kγ Inhibitors

ACS medicinal chemistry letters, 2021-01, Vol.12 (1), p.129-135

2021

Volltextzugriff (PDF)

Synthesis of a 6‑Aza-Isoindolinone-Based Inhibitor of Phosphoinositide 3‑Kinase γ via Ruthenium-Catalyzed [2 + 2 + 2] Cyclotrimerization

ACS medicinal chemistry letters, 2019-01, Vol.10 (1), p.117-120

2019

Volltextzugriff (PDF)

A model for identifying HERG K + channel blockers

Bioorganic & medicinal chemistry, 2004-05, Vol.12 (9), p.2307-2315

2004

Volltextzugriff (PDF)

Flipped Out: Structure-Guided Design of Selective Pyrazolylpyrrole ERK Inhibitors

Journal of medicinal chemistry, 2007-03, Vol.50 (6), p.1280-1287

2007

Volltextzugriff (PDF)

Toward a Pharmacophore for Kinase Frequent Hitters

Journal of medicinal chemistry, 2004-11, Vol.47 (23), p.5616-5619

2004

Volltextzugriff (PDF)

A minimalist approach to fragment-based ligand design using common rings and linkers: Application to kinase inhibitors

Proteins, structure, function, and bioinformatics, 2004-10, Vol.57 (1), p.36-50

2004

Volltextzugriff (PDF)

Structure-Based Design of Submicromolar, Biologically Active Inhibitors of Trypanosomatid Glyceraldehyde-3-Phosphate Dehydrogenase

Proceedings of the National Academy of Sciences - PNAS, 1999-04, Vol.96 (8), p.4273-4278

1999

Volltextzugriff (PDF)

Adenosine Analogues as Selective Inhibitors of Glyceraldehyde-3-phosphate Dehydrogenase of Trypanosomatidae via Structure-Based Drug Design

Journal of medicinal chemistry, 2001-06, Vol.44 (13), p.2080-2093

2001

Volltextzugriff (PDF)

Erratum: Drug discovery effectiveness from the standpoint of therapeutic mechanisms and indications

Nature reviews. Drug discovery, 2018, Vol.17 (1), p.78-78

2018

Volltextzugriff (PDF)

Selective Tight Binding Inhibitors of Trypanosomal Glyceraldehyde-3-phosphate Dehydrogenase via Structure-Based Drug Design

Journal of medicinal chemistry, 1998-11, Vol.41 (24), p.4790-4799

1998

Volltextzugriff (PDF)

1 – 25 von 45

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(37)
Mit Volltextzugriff
(37)

Publikationsform

Sprache

Englisch
(45)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Drug discovery effectiveness from the standpoint of therapeutic mechanisms and indications

Common Pharmacophores for Uncharged Human Ether-a-go-go-Related Gene (hERG) Blockers

Predictive in silico modeling for hERG channel blockers

Targeting the MAPK Signaling Pathway in Cancer: Promising Preclinical Activity with the Novel Selective ERK1/2 Inhibitor BVD-523 (Ulixertinib)

Drug discovery effectiveness from the standpoint of therapeutic mechanisms and indications

Ligand structural aspects of hERG channel blockade

Prediction of Protein Pairs Sharing Common Active Ligands Using Protein Sequence, Structure, and Ligand Similarity

Structural Basis for Isoform Selectivity in a Class of Benzothiazole Inhibitors of Phosphoinositide 3‑Kinase γ

Kinase-likeness and Kinase-Privileged Fragments: Toward Virtual Polypharmacology

Design and Synthesis of a Novel Series of Orally Bioavailable, CNS-Penetrant, Isoform Selective Phosphoinositide 3‑Kinase γ (PI3Kγ) Inhibitors with Potential for the Treatment of Multiple Sclerosis (MS)

Smallest Maximum Intramolecular Distance: A Novel Method to Mitigate Pregnane Xenobiotic Receptor Activation

Fragment-Based Discovery of Dual JC Virus and BK Virus Helicase Inhibitors

Structure-Guided Design of Potent and Selective Pyrimidylpyrrole Inhibitors of Extracellular Signal-Regulated Kinase (ERK) Using Conformational Control

Discovery of Potent, Selective Triazolothiadiazole-Containing c‑Met Inhibitors

Discovery of Highly Isoform Selective Thiazolopiperidine Inhibitors of Phosphoinositide 3‑Kinase γ

Discovery of a Novel Series of Potent and Selective Alkynylthiazole-Derived PI3Kγ Inhibitors

Synthesis of a 6‑Aza-Isoindolinone-Based Inhibitor of Phosphoinositide 3‑Kinase γ via Ruthenium-Catalyzed [2 + 2 + 2] Cyclotrimerization

A model for identifying HERG K + channel blockers

Flipped Out: Structure-Guided Design of Selective Pyrazolylpyrrole ERK Inhibitors

Toward a Pharmacophore for Kinase Frequent Hitters

A minimalist approach to fragment-based ligand design using common rings and linkers: Application to kinase inhibitors

Structure-Based Design of Submicromolar, Biologically Active Inhibitors of Trypanosomatid Glyceraldehyde-3-Phosphate Dehydrogenase

Adenosine Analogues as Selective Inhibitors of Glyceraldehyde-3-phosphate Dehydrogenase of Trypanosomatidae via Structure-Based Drug Design

Erratum: Drug discovery effectiveness from the standpoint of therapeutic mechanisms and indications

Selective Tight Binding Inhibitors of Trypanosomal Glyceraldehyde-3-phosphate Dehydrogenase via Structure-Based Drug Design

Suchergebnisse filtern